Who owns ImmuCell Corporation?

Tip: Access positions for across all investors

Analyze quarterly positions in ImmuCell Corporation with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of ImmuCell Corporation stock

Who bought or sold ImmuCell Corporation this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Vanguard Group 303k $1.9M -2% Dec 2025
 View chart
Renaissance Technologies 151k $927k -4% Dec 2025
 View chart
Cresset Asset Management 135k $832k 2% Dec 2025
 View chart
Bleichroeder 102k $625k 0% Dec 2025
 View chart
Geode Capital Management 72k $445k 0% Dec 2025
 View chart
Steadtrust 57k $349k 79% Dec 2025
 View chart
Dimensional Fund Advisors 54k $334k -13% Dec 2025
 View chart
Dauntless Investment Group 40k $244k -55% Dec 2025
 View chart
Northern Trust 38k $234k 1% Dec 2025
 View chart
Alan Leist III 37k $231k 0% Dec 2025
 View chart
Mesirow Financial Investment Management International Equity 37k $224k 200% Dec 2025
 View chart
Shufro Rose & Co 35k $215k -43% Dec 2025
 View chart
Citadel Advisors 22k $139k -48% Sep 2025
 View chart
HighTower Advisors 19k $119k -9% Dec 2025
 View chart
BlackRock 16k $100k 0% Dec 2025
 View chart
Essex Financial Services 11k $68k 0% Dec 2025
 View chart
Hm Payson & Co 4.0k $25k 0% Dec 2025
 View chart
UBS Group 1.6k $9.9k 61% Dec 2025
 View chart
Flagship Harbor Advisors 730.00 $4.5k 100% Dec 2025
 View chart
Advisor Group Holdings 391.00 $2.4k 0% Dec 2025
 View chart
Harbour Investments 250.00 $1.5k 100% Dec 2025
 View chart
Capital Advisors 98.00 $1.0k 0% Dec 2025
 View chart
Jones Financial Companies, L.L 19.00 $114.999400 0% Sep 2025
 View chart
Wells Fargo & Company 1.00 $4.000000 0% Dec 2025
 View chart
Royal Bank of Canada 1.00 $0 100% Sep 2025
 View chart

Who sold out of ImmuCell Corporation?

Fund or Company Name Date Sold Shares Held Valued At
Barclays Sep 2025 7.00 $43.999900